Drug Patent Watch

DECEMBER 10, 2024

This shift has led to the emergence of integrated contract development and manufacturing organizations (CDMOs), which provide end-to-end support for drug developers. In this article, we will delve into the benefits of working with integrated CDMO services and explore how they can streamline the drug development and manufacturing process.

Drug Development 96

Drug Development Compliance Pharmaceutical Companies Drugs 96

NIOSH Science Blog: Drugs

JUNE 22, 2023

June 23, 2023 is International Women in Engineering Day. To celebrate International Women in Engineering Day we are highlighting some of the amazing engineers right here at NIOSH. In the United States, women make up 14% of the engineering workforce (15% internationally).[1] Barb Alexander, PhD, PE, CIH Dr. Alexander has worked in

Engineering 98

Engineering International 98

Drug Patent Watch

DECEMBER 10, 2024

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

Government 97

Government Drugs Pharmacy Pharmaceuticals 97

Drug Patent Watch

DECEMBER 9, 2024

This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. But what exactly is pharmacognosy, and how does it relate to the complex world of drug patents? This approach has led to the discovery of numerous potential drug candidates. What is a Drug Patent?

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

PPD

OCTOBER 21, 2024

Meeting the never-ending challenges of drug development in this active environment — including pressure to identify drug prospects earlier and hire more conservatively — frequently leads biotech companies to outsource some portion of clinical development functions.

International 87

International Clinical Development Clinical Trials Clinical Research 87

Collaborative Drug

JANUARY 24, 2024

Date: February 3rd to 7th 2024 Location: Boston Convention and Exhibition Center Boston, MA, Collaborative Drug Discovery (CDD) is excited to announce our participation in SLAS 2024 International Conference & Exhibition , from February 3rd to 7th at the Boston Convention and Exhibition Center.

Laboratories 273

Laboratories International Drugs 273

Drug Target Review

JANUARY 14, 2025

Drug discovery scientists spend their days developing and testing complex hypotheses, leveraging data and expertise through workflows that utilise available tools. Defining the research question A well-defined research question is the cornerstone of an effective scientific workflow in drug discovery. provide more general information.

Drugs 69

Drugs Protein Expression Science Research 69

Drug Channels

NOVEMBER 15, 2024

The authors outline the challenges that manufacturers face when integrating internal and external datasets to build market access and commercialization strategies. TThey argue that unified datasets and the addition of AI-driven analytics tools can improve decision making throughout a drug’s life cycle. Read on for their insights.

Marketing 98

Marketing International Drugs 98

Science Daily: Pharmacology News

FEBRUARY 19, 2024

Hydrogels are already used in clinical practice for the delivery of drugs, and as lenses, bone cement, wound dressings, 3D scaffolds in tissue engineering and other applications. They used their approach to locally protect and cool tissues, seal vascular injuries, and prevent unwanted 'surgical adhesions' of internal body surfaces.

Engineering 219

Engineering International Research Drugs 219

Drug Patent Watch

JULY 28, 2024

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source

International 97

International Drugs 97

FDA Law Blog: Biosimilars

APRIL 1, 2025

By Dr. Naomi Lowy, Principal Drug Regulatory Expert Trade and national press have reported that recent changes in FDA staffing levels have already led to slower responses to calls and emails. This coupled with more recent reports raised the specter of FDA falling short of user fee goals. Therein lies the opportunity.

FDA 77

FDA International Drug Development Drugs 77

Collaborative Drug

AUGUST 15, 2023

Company Named as a Sample Vendor for SaaS Electronic Lab Notebook San Francisco, CA - August 15, 2023 - Collaborative Drug Discovery (CDD) is proud to announce its recent recognition as a Sample Vendor for Software-as-a-Service (SaaS) Electronic Laboratory Notebook (ELN) in the Gartner Hype Cycle for Life Science Discovery Research, 2023 report.

Science 245

Science Research Compliance International 245

Drug Patent Watch

DECEMBER 30, 2024

The regulatory environment in Japan for generic drug development is complex and has undergone significant changes in recent years. Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA) The PMDA is the primary regulatory authority responsible for overseeing the drug approval process in Japan.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Collaborative Drug

AUGUST 15, 2023

Company Named as a Sample Vendor for SaaS Electronic Lab Notebook San Francisco, CA - August 15, 2023 - Collaborative Drug Discovery (CDD) is proud to announce its recent recognition as a Sample Vendor for Software-as-a-Service (SaaS) Electronic Laboratory Notebook (ELN) in the Gartner Hype Cycle for Life Science Discovery Research, 2023 report.

Science 240

Science Research Compliance International 240

New Drug Approvals

APRIL 11, 2025

1] [2] Adverse effects The US Food and Drug Administration prescription label for fitusiran contains a boxed warning for thrombotic events (blood clotting) and gallbladder disease (with some recipients requiring gallbladder removal). [2] 2] [3] Names Fitusiran is the international nonproprietary name. [4] Food and Drug Administration.

Clinical Trials 107

Clinical Trials FDA FDA Approval Trials 107

Covalent Modifiers

JANUARY 13, 2024

Thomas Kodadek Angewandte Chemie International Edition 2024 e202316726 [link] Many of the highest priority targets in a wide range of disease states are difficult-to-drug proteins.

Small Molecule 195

Small Molecule International Disease Drugs 195

Drug Discovery Today

JUNE 10, 2020

For 2020 the BIO International Convention, usually one the world’s largest gatherings of the global biotech industry, is transitioning to a new, virtual event format. This is part of the main BIO programme which will be aired on Wednesday 10th June, with live Q&A.

International 124

International Drugs Science 124

Drug Target Review

OCTOBER 30, 2024

Now take a step further: envision testing drugs in these organoids to identify the ones that can treat disease safely and effectively without needing to run expensive clinical trials first. 12 Testing drugs in vitro in organoid cultures A clear validation of the utility of organoids is in drug discovery and development.

Treatment 105

Treatment Disease Clinical Trials Molecular Biology 105

PPD

DECEMBER 16, 2024

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

Drug Development 52

Drug Development Clinical Trials Compliance Trials 52

Drug Patent Watch

APRIL 11, 2024

A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to overcoming the financial barriers associated with repurposing generic drugs through… Source

Drugs 105

Drugs International 105

Drug Target Review

DECEMBER 6, 2024

In drug discovery and biological research, the scientists workflow often follows a structured and iterative approach to ensure accuracy, reproducibility and scientific integrity. Figure 1: High-level workflow for early drug discovery Once the raw data has been gathered, the next step is to gain a thorough understanding of the data.

RNA 52

RNA Drugs Research Science 52

PPD

OCTOBER 31, 2024

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

NIOSH Science Blog: Drugs

APRIL 10, 2024

Struck-by injuries are the leading cause of nonfatal injuries and second most common cause of fatalities among construction workers. From 2011 to 2022, there were 1,462 fatal occupational injuries that occurred at road construction sites.[1]

International 113

International 113

Drug Target Review

JANUARY 8, 2024

fowleri – self-activating guanine nucleotide-hydrolysing proteins (G proteins) – that present novel targets for drug discovery. From a database of more than 200,000 high-resolution, three-dimensional images of human induced pluripotent stem cells, researchers have devised a model to quantify cell shape and internal organisation.

Drugs 111

Drugs International Science Research 111

Covalent Modifiers

SEPTEMBER 9, 2023

3c00297 Falling in between traditional small molecules and antibodies in size, peptides are emerging as a privileged therapeutic modality, one that can harness the benefits of both small molecule and antibody drugs. Mengmeng Zheng and Jianmin Gao ACS Chemical Biology 2023 DOI: 10.1021/acschembio.3c00297

Small Molecule 195

Small Molecule International Drugs 195

Drug Patent Watch

FEBRUARY 27, 2025

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. But what can you do to protect your drug patent in global markets? Read the full article here: [link]

Marketing 52

Marketing Drugs Regulations Pharmaceutical Companies 52

Drug Target Review

DECEMBER 11, 2024

This shift in focus is especially critical in toxicology, where accurate target analysis plays a vital role in identifying toxic effects and ensuring patient safety, particularly as the field transitions from traditional drugs to the promising realm of biotherapeutics, especially for rare diseases.

International 52

International Laboratories Drugs Pharmacokinetics 52

FDA Law Blog: Drug Discovery

APRIL 21, 2025

One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a leadership vacuum at the Center for Drug Evaluation and Research (CDER).

FDA 64

FDA Drug Development Drugs International 64

Drug Patent Watch

OCTOBER 12, 2021

International License Abstract Development of generic drug product…. The post Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review appeared first on DrugPatentWatch - Make Better Decisions. This paper was originally published by Md.

Production 105

Production Pharmaceuticals Licensing Licensing 105

SCIENMAG: Medicine & Health

NOVEMBER 22, 2023

Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine. Credit: Photo: Stefan Zimmerman Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development (..)

Disease 91

Disease Drugs International Research 91

Drug Patent Watch

JULY 13, 2020

Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…. The post Common Drugs with Effective Off-Label Uses appeared first on DrugPatentWatch - Make Better Decisions. This article was originally published by Mohammed M. Alshehri and Mahmoud M.

Licensing 94

Licensing Licensing Drugs International 94

Drug Discovery Today

NOVEMBER 10, 2022

A team of surgeons and scientists from the UK, Sweden and Canada, funded by Rinri Therapeutics, has confirmed secure surgical access to the central core of the human cochlea The research, published in Scientific Reports, is critical to the first in-human trials of new cell, gene and drug therapies for the inner ear, and will assist with treatment for (..)

International 100

International Research Therapies Trials 100

SCIENMAG: Medicine & Health

MARCH 26, 2024

Credit: Redox Medicine […]

Small Molecule 78

Small Molecule International Drug Development Drugs 78

Drug Channels

FEBRUARY 7, 2022

Drug Pricing Transparency Congress. Hybrid Event March 28-29, 2022 | Philadelphia, PA www.informaconnect.com/drug-pricing-transparency. Don’t miss the Drug Pricing Transparency Congress on March 28-29, 2022! Visit www.informaconnect.com/drug-pricing-transparency for further details and to register.

Drugs 97

Drugs Compliance International Regulations 97

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Hospitals 81

Hospitals Biosimilars Pharmacy Drugs 81

Drug Target Review

APRIL 7, 2025

In a recent survey conducted by ICON, Plc, biomarker selection was identified by 35 percent of respondents as a top challenge among drug developers for phase I trials, second only to navigating regulatory compliance (- 38 percent). To qualify as endpoints, biomarkers used in early phases must be relevant to later stages of drug development.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Zobio

AUGUST 26, 2024

In person ZoBio was present in Rome for the XXVIII EFMC International Symposium on Medicinal Chemistry. The 2024 program promised to be as interesting and diverse as ever, covering significant advances in drug discovery across major therapeutic areas and it truly was.

International 40

International Drugs 40